Skip to main navigation Skip to search Skip to main content

Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study

  • Vivianne M. Sloeserwij*
  • , Dorien L.M. Zwart
  • , Ankie C.M. Hazen
  • , Judith M. Poldervaart
  • , Anne J. Leendertse
  • , Antoinette A. de Bont
  • , Marcel L. Bouvy
  • , Niek J. de Wit
  • , Han J. de Gier
  • *Corresponding author for this work
  • Erasmus University Rotterdam
  • University of Groningen

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background Especially in elderly with polypharmacy, medication can do harm. Clinical pharmacists integrated in primary care teams might improve quality of pharmaceutical care. Objective To assess the effect of non-dispensing clinical pharmacists integrated in primary care teams on general practitioners’ prescribing quality. Setting This study was conducted in 25 primary care practices in the Netherlands. Methods Non-randomised, controlled, multi-centre, complex intervention study with pre-post comparison. First, we identified potential prescribing quality indicators from the literature and assessed their feasibility, validity, acceptability, reliability and sensitivity to change. Also, an expert panel assessed the indicators’ health impact. Next, using the final set of indicators, we measured the quality of prescribing in practices where non-dispensing pharmacists were integrated in the team (intervention group) compared to usual care (two control groups). Data were extracted anonymously from the healthcare records. Comparisons were made using mixed models correcting for potential confounders. Main outcome measure Quality of prescribing, measured with prescribing quality indicators. Results Of 388 eligible indicators reported in the literature we selected 8. In addition, two more indicators relevant for Dutch general practice were formulated by an expert panel. Scores on all 10 indicators improved in the intervention group after introduction of the non-dispensing pharmacist. However, when compared to control groups, prescribing quality improved solely on the indicator measuring monitoring of the renal function in patients using antihypertensive medication: relative risk of a monitored renal function in the intervention group compared to usual care: 1.03 (95% CI 1.01–1.05, p-value 0.010) and compared to usual care plus: 1.04 (1.01–1.06, p-value 0.004). Conclusion This study did not demonstrate a consistent effect of the introduction of non-dispensing clinical pharmacists in the primary care team on the quality of physician’s prescribing. This study is part of the POINT-study, which was registered at The Netherlands National Trial Register with trial registration number NTR‐4389.

Original languageEnglish
Pages (from-to)1293-1303
Number of pages11
JournalInternational Journal of Clinical Pharmacy
Volume42
Issue number5
DOIs
Publication statusPublished - 1 Oct 2020

Funding

A research grant was obtained from the Netherlands Organisation for Health Research and Development (Grant Agreement Number 80-833600-98-10206). Implementation of NDPs was financed by an unconditional grant of the Foundation Achmea Healthcare, a Dutch health insurance company (Project Number Z456). Both study sponsors had no role in the design of the study, nor in the data collection, analyses, interpretation of the data and in the writing of the report or in the decision to submit the manuscript for publication.

Keywords

  • Non-dispensing pharmacist
  • Pharmaceutical care
  • Prescribing
  • Process indicator
  • Quality

Fingerprint

Dive into the research topics of 'Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study'. Together they form a unique fingerprint.

Cite this